TY - JOUR
T1 - Effect of surfactant and specific antibody on bacterial proliferation and lung function in experimental pneumococcal pneumonia
AU - Gan, Xiaozhuang
AU - Jarstrand, Connie
AU - Herting, Egbert
AU - Berggren, Per
AU - Robertson, Bengt
N1 - Funding Information:
Supported by the Swedish Medical King Oscar II Jubliee Foundation, Institute, and the Swedish Institute Research Council (Project No. 3351). the Research Funds of Karolinska (travel grant for X. Gan).
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - Objective: To investigate the effect of surfactant and specific antibody on bacterial proliferation in experimental pneumococcal pneumonia. Methods: Near-term newborn rabbits received a standard dose (107) of type 3 pneumococci via the airways. Control animals were sacrificed 1 minute later. Other animals were ventilated for 5 hours and treated via the tracheal cannula with surfactant (Curosurf 200 mg/kg), a mixture of surfactant and a polyclonal antipneumococcal antibody, the antibody without surfactant, or saline. Results: There was a significant bacterial proliferation in lung tissue in all animals ventilated for 5 hours. Bacterial growth, expressed as log10 colony forming units (CFU) per gram of lung tissue was less prominent in animals treated with a mixture of surfactant and specific antibody than in animals treated with antibody alone (median, 7.51, range, 6.80-7.70 vs. median, 7.92, range, 7.07-8.50; P < 0.05). Dynamic lung-thorax compliance was improved with surfactant or surfactant plus antibody in comparison with saline or antibody alone. Conclusion: The data suggest that the suppressive effect of the antibody on bacterial proliferation becomes evident only when surfactant is administered together with the antibody.
AB - Objective: To investigate the effect of surfactant and specific antibody on bacterial proliferation in experimental pneumococcal pneumonia. Methods: Near-term newborn rabbits received a standard dose (107) of type 3 pneumococci via the airways. Control animals were sacrificed 1 minute later. Other animals were ventilated for 5 hours and treated via the tracheal cannula with surfactant (Curosurf 200 mg/kg), a mixture of surfactant and a polyclonal antipneumococcal antibody, the antibody without surfactant, or saline. Results: There was a significant bacterial proliferation in lung tissue in all animals ventilated for 5 hours. Bacterial growth, expressed as log10 colony forming units (CFU) per gram of lung tissue was less prominent in animals treated with a mixture of surfactant and specific antibody than in animals treated with antibody alone (median, 7.51, range, 6.80-7.70 vs. median, 7.92, range, 7.07-8.50; P < 0.05). Dynamic lung-thorax compliance was improved with surfactant or surfactant plus antibody in comparison with saline or antibody alone. Conclusion: The data suggest that the suppressive effect of the antibody on bacterial proliferation becomes evident only when surfactant is administered together with the antibody.
UR - http://www.scopus.com/inward/record.url?scp=0035044653&partnerID=8YFLogxK
U2 - 10.1016/S1201-9712(01)90042-6
DO - 10.1016/S1201-9712(01)90042-6
M3 - Journal articles
C2 - 11285153
AN - SCOPUS:0035044653
SN - 1201-9712
VL - 5
SP - 9
EP - 18
JO - International Journal of Infectious Diseases
JF - International Journal of Infectious Diseases
IS - 1
ER -